
     RDKit          3D

 16 16  0  0  1  0  0  0  0  0999 V2000
    0.9645   -0.0903    0.0059 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0166    1.6476   -1.7375 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0854    1.2798   -0.3526 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0928    4.5549   -0.3590 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7426    3.7275    0.7036 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2712    5.1478   -0.0269 C   0  0  1  0  0  0  0  0  0  0  0  0
    0.8844    2.3496    0.6737 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3580    4.0782    1.9286 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1590    6.2623    1.0087 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4551    1.3184   -0.3342 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8739    5.7045   -1.2941 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.7523    3.0196    2.6340 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.4825    5.3106    2.3826 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1624    7.4505    0.7384 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1491    5.8066    2.2776 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.4601    1.9243    1.8346 O   0  0  0  0  0  0  0  0  0  0  0  0
  5  4  1  0
  6  4  1  0
  6 11  1  6
  7  5  2  0
  8  5  1  0
  9  6  1  0
 10  1  1  0
 10  2  1  0
 10  3  1  0
 10  7  1  0
 12  8  2  0
 13  8  1  0
 14  9  2  0
 15  9  1  0
 16  7  1  0
 16 12  1  0
M  CHG  1  13  -1
M  END
>  <DRUGBANK_ID>  (1) 
DB03319

>  <SECONDARY_ACCESSION_NUMBERS>  (1) 
EXPT00882

>  <COMMON_NAME>  (1) 
(2S)-2-Ammonio-3-[5-(2-methyl-2-propanyl)-3-oxido-1,2-oxazol-4-yl]propanoate

$$$$
